1-4 of 4
Mengmeng Ji
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Auto-HSCT Vs CAR-T Cell Therapy for Paients with Relapsed/Refractory DLBCL in Partial Remission with Deauville Score of 4 or 5 after Salvage Chemotherapy

Siyuan Chen, Li Wang, Pengpeng Xu, Shu Cheng, Wei Tang, Wen Wu, Mengmeng Ji, Zhong Zheng, Zixun Yan, Lingshuang Sheng, Yige Shen, Weili Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6553.
https://doi.org/10.1182/blood-2024-203842
Published: 2024
Journal Articles

Efficacy and Safety of Chidamide Combined with BEAM Conditioning Regimen in Autologous Transplantation for T-Cell Lymphoma

Yige Shen, Zhong Zheng, Mengmeng Ji, Wei Tang, Wei Li Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 3602.
https://doi.org/10.1182/blood-2023-177562
Published: 2023
Journal Articles

CEOP/IVE/GDP Alternating Regimen Compared with CEOP As the First-Line Therapy for Newly Diagnosed Patients with Peripheral T-Cell Lymphoma: Results from a Phase 2, Multi-Center, Randomized, Controlled Clinical Trial

Mingci Cai, MD, Shu Cheng, MD PhD, Wang Xin, PhD, Jianda Hu, PhD, Yongping Song, Zixun Yan, Yujie Jiang, MD, Xiaosheng Fang, PhD, Xiaoyun Zheng, Lihua Dong, Mengmeng Ji, Li Wang, MD PhD, Pengpeng Xu, Weili Zhao
Journal: Blood
Blood (2019) 134 (Supplement_1): 1556.
https://doi.org/10.1182/blood-2019-122369
Published: 2019
Journal Articles

Histone-Modifying Gene Mutations Are Related to Tumor Progression and Response to Histone Deacetylase Inhibitors in Patients with Peripheral T-Cell Lymphoma Not Otherwise Specified

Mengmeng Ji, PhD
Journal: Blood
Blood (2016) 128 (22): 4110.
https://doi.org/10.1182/blood.V128.22.4110.4110
Published: 2016